Search results
Results from the WOW.Com Content Network
epocrates is a widely used mobile medical reference application that provides healthcare professionals with access to clinical information at the point of care. The software is designed to assist physicians, pharmacists, nurse practitioners, physician assistants and other healthcare providers in making informed decisions about drug interactions, medical calculations, diagnosis and treatment ...
Epocrates, Inc., now an athenahealth company, is recognized for developing the #1 medical application among U.S. physicians for clinical content, practice tools, and health industry engagement at ...
Hippocrates. Hippocrates of Kos (/ hɪˈpɒkrətiːz /, Greek: Ἱπποκράτης ὁ Κῷος, translit. Hippokrátēs ho Kôios; c. 460 – c. 370 BC), also known as Hippocrates II, was a Greek physician and philosopher of the classical period who is considered one of the most outstanding figures in the history of medicine. He is ...
Epicrates Boulenger, 1893. Boella. H.M. Smith & Chiszar, 1992[1] Epicrates is a genus of non- venomous snakes in the subfamily Boinae of the family Boidae. The genus is native to South America and Central America. Five species are currently recognized as being valid, including the rainbow boa. [2]
Massachussetts-based athenahealth just stirred things up a bit in the physician software market. The company announced Monday that it planned to buy point-of-care software provider Epocrates for ...
Epocrates (NAS: EPOC) reported earnings on May 1. Here are the numbers you need to know. The 10-second takeawayFor the quarter ended March 31 (Q1), Epocrates beat expectations on revenues and beat ...
Margins matter. The more Epocrates (NAS: EPOC) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders.
Erythropoietin is an essential hormone for red blood cell production. Without it, definitive erythropoiesis does not take place. Under hypoxic conditions, the kidney will produce and secrete erythropoietin to increase the production of red blood cells by targeting CFU-E, pro erythroblast and basophilic erythroblast subsets in the differentiation.